Trial Outcomes & Findings for Comparing Two Forms of Head Immobilization for Stereotactic Radiotherapy (NCT NCT00328510)

NCT ID: NCT00328510

Last Updated: 2016-11-29

Results Overview

This study uses the ExacTRAC imaging system to assess positioning of frame or mask during SRT. Images yield lateral, longitudinal, and vertical deviations of the isocenter as well as head rotations about respective axes.

Recruitment status

COMPLETED

Study phase

PHASE3

Target enrollment

83 participants

Primary outcome timeframe

Measurements taken during SRT

Results posted on

2016-11-29

Participant Flow

Participant milestones

Participant milestones
Measure
GTC Frame
Participant undergoes SRT using a GTC frame to immobilize the participant's heading during radiation therapy
BrainLab Thermoplastic Mask
Participant undergoes SRT using the BrainLab thermoplastic mask to immobilize the participant's head during radiation therapy
Overall Study
STARTED
42
41
Overall Study
COMPLETED
32
37
Overall Study
NOT COMPLETED
10
4

Reasons for withdrawal

Reasons for withdrawal
Measure
GTC Frame
Participant undergoes SRT using a GTC frame to immobilize the participant's heading during radiation therapy
BrainLab Thermoplastic Mask
Participant undergoes SRT using the BrainLab thermoplastic mask to immobilize the participant's head during radiation therapy
Overall Study
Gag disorder, could not use frame
4
0
Overall Study
Dentition problems, could not use frame
1
0
Overall Study
Withdrawal by Subject
4
2
Overall Study
Severe kyphosis, could not use mask
0
1
Overall Study
Treatment changed to a single fraction
1
1

Baseline Characteristics

Comparing Two Forms of Head Immobilization for Stereotactic Radiotherapy

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
GTC Frame
n=42 Participants
Participant undergoes SRT using a GTC frame to immobilize the participant's heading during radiation therapy
BrainLab Thermoplastic Mask
n=41 Participants
Participant undergoes SRT using the BrainLab thermoplastic mask to immobilize the participant's head during radiation therapy
Total
n=83 Participants
Total of all reporting groups
Sex: Female, Male
Male
17 Participants
n=5 Participants
19 Participants
n=7 Participants
36 Participants
n=5 Participants
Region of Enrollment
United States
42 participants
n=5 Participants
41 participants
n=7 Participants
83 participants
n=5 Participants
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
31 Participants
n=5 Participants
30 Participants
n=7 Participants
61 Participants
n=5 Participants
Age, Categorical
>=65 years
11 Participants
n=5 Participants
11 Participants
n=7 Participants
22 Participants
n=5 Participants
Age, Continuous
55.43 years
STANDARD_DEVIATION 14.93 • n=5 Participants
56.94 years
STANDARD_DEVIATION 14.07 • n=7 Participants
56.18 years
STANDARD_DEVIATION 14.44 • n=5 Participants
Sex: Female, Male
Female
25 Participants
n=5 Participants
22 Participants
n=7 Participants
47 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Measurements taken during SRT

This study uses the ExacTRAC imaging system to assess positioning of frame or mask during SRT. Images yield lateral, longitudinal, and vertical deviations of the isocenter as well as head rotations about respective axes.

Outcome measures

Outcome measures
Measure
GTC Frame
n=714 Measurements
Participant undergoes SRT using a GTC frame to immobilize the participant's heading during radiation therapy
BrainLab Thermoplastic Mask
n=782 Measurements
Participant undergoes SRT using the BrainLab thermoplastic mask to immobilize the participant's head during radiation therapy
Distance From Ideal to Center of GTC Frame and BrainLab Thermoplastic Mask With Respect to Average and Variability
2.00 millimeters
Standard Deviation 1.04
3.17 millimeters
Standard Deviation 1.95

Adverse Events

GTC Frame

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

BrainLab Thermoplastic Mask

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Maria Werner-Wasik, MD

Thomas Jefferson University

Phone: 215-955-7679

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place